This Article Full Text Full Text (PDF) All Versions of this Article: 147/7/3318    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, L.-X. Articles by Brubaker, P. L. Search for Related Content PubMed PubMed Citation Articles by Li, L.-X. Articles by Brubaker, P. L.

Role of Phosphatidylinositol 3-Kinase in the ß-Cell: Interactions with Glucagon-Like Peptide-1

Departments of Physiology (L.-X.L., D.S.A., G.Y.O., P.H.B., P.L.B.) and Medicine (G.Y.O., P.H.B., P.L.B.), and Heart and Stroke/Richard Lewar Centre of Excellence (G.Y.O., P.H.B.), University of Toronto, Toronto, Ontario, Canada M5S 1A8; Department of Experimental Medical Science (P.E.M.), Lund University, S-221 84 Lund, Sweden; and Oxford Centre for Diabetes, Endocrinology, and Metabolism (P.E.M.), Oxford OX3 7LJ, United Kingdom

Address all correspondence and requests for reprints to: Dr. Patricia Brubaker, Room 3366 Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada M5S 1A8. E-mail: p.brubaker{at}utoronto.ca.

Glucagon-like peptide-1 (GLP-1) increases ß-cell function and growth through protein kinase A- and phosphatidylinositol-3-kinase (PI3-K)/protein kinase B, respectively. GLP-1 acts via a G protein-coupled receptor, and PI3-K is known to be activated by G_ß. Therefore, the role of PI3-K in the chronic effects of GLP-1 on the ß-cell was investigated using PI3-K knockout (KO) mice treated with the GLP-1 receptor agonist, exendin-4 (Ex4; 1 nmol/kg sc every 24 h for 14 d). In vivo, glucose and insulin responses were similar in PBS- and Ex4-treated KO and wild-type (WT) mice. However, glucose-stimulated insulin secretion was markedly impaired in islets from PBS-KO mice (P < 0.05), and this was partially normalized by chronic Ex4 treatment (P < 0.05). In contrast, insulin content was increased in PBS-KO islets, and this was paradoxically decreased by Ex4 treatment, compared with the stimulatory effect of Ex4 on WT islets (P < 0.05–0.01). Transfection of INS-1E ß-cells with small interfering RNA for PI3-K similarly decreased glucose-stimulated insulin secretion (P < 0.01) and increased insulin content. Basal values for ß-cell mass, islet number and proliferation, glucose transporter 2, glucokinase, and insulin receptor substrate-2 were increased in PBS-KO mice (P < 0.05–0.001) and, although they were increased by Ex4 treatment of WT animals (P < 0.05), they were decreased in Ex4-KO mice (P < 0.05–0.01). These findings indicate that PI3-K deficiency impairs insulin secretion, resulting in compensatory islet growth to maintain normoglycemia. Chronic Ex4 treatment normalizes the secretory defect, thereby relieving the pressure for expansion of ß-cell mass. These studies reveal a new role for PI3-K as a positive regulator of insulin secretion, and reinforce the importance of GLP-1 for the maintenance of normal ß-cell function.

This article has been cited by other articles:

				Z. Liu and J. F. Habener Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation J. Biol. Chem., March 28, 2008; 283(13): 8723 - 8735. [Abstract] [Full Text] [PDF]

				Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF]